Clinical Research Directory

Inclusion Criteria: * A negative urine pregnancy test, if female subject of childbearing potential. * Able to speak English and complete study forms, adhere to treatment regimens, and be willing to return for regular visits. * After full explanation of the study, willingness of participant is demonstrated by signing the informed consent form. Exclusion Criteria: * Clinically unstable medical disease: * cardiovascular * renal * gastrointestinal * pulmonary * metabolic * endocrine * other * CNS disease deemed progressive * Moderate or severe traumatic brain injury (TBI) * Pregnant females or those currently breast-feeding. * Current or history of schizophrenia or other psychotic disorder, except psychosis not otherwise specified (NOS) when the presence of sensory hallucinations is clearly related to the subject's trauma, Bipolar Type I disorder, or dementia: * vascular * Alzheimer's disease * other types * Repeated abuse or dependence upon drugs (excluding nicotine and caffeine) within 6 days of study entry, with the exception of alcohol use disorder, which, at the discretion of the study team, may be permitted. See further explanation under protection from risk. * Active participation or plan for enrollment in another evidence-based psychotherapeutic clinical trial * Participation in other psychotherapeutic modalities must have been stable for 3 months prior to enrollment and must remain stable throughout participation. * Currently taking medications that have short half-lives, lower the seizure threshold, and do not have evidence of antidepressant efficacy. These include: * high dose theophylline or stimulants such as methylphenidate patients taking bupropion must be on a stable dose and take less than or equal to 300 mg/day. Stable means the same dose for 5 half-lives. * An implanted device in subject's head (shunt, cochlear implant) and/or metal in subject's head (other than dental implant). * History of seizures or a seizure disorder.